HomeKRRO • NASDAQ
Korro Bio Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.55M | — |
Operating expense | 27.57M | 28.51% |
Net income | -23.39M | -19.58% |
Net profit margin | -917.14 | — |
Earnings per share | -2.49 | -2.05% |
EBITDA | -23.80M | -14.80% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 114.95M | -17.18% |
Total assets | 202.21M | 2.13% |
Total liabilities | 63.25M | 35.65% |
Total equity | 138.96M | — |
Shares outstanding | 9.39M | — |
Price to book | 1.06 | — |
Return on assets | -29.20% | — |
Return on capital | -32.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.39M | -19.58% |
Cash from operations | -24.45M | -11.70% |
Cash from investing | 32.78M | 684.23% |
Cash from financing | 172.00K | 23.74% |
Net change in cash | 8.50M | 131.07% |
Free cash flow | -16.72M | 34.12% |
Previous close
$15.71
Day range
$14.96 - $16.68
Year range
$11.13 - $98.00
Market cap
151.94M USD
Avg Volume
97.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
112
